THG filed a Form 144 notice reporting a sale of securities by Denise Lowsley. The notice lists 4,175 shares associated with an option granted 02/26/2021 and a transaction date of 05/14/2026. The excerpt also shows 1,062 shares sold in the past three months for $200,107.35, and a figure of $800,472.75 alongside the 4,175‑share line. Shares outstanding are listed as 34,986,787 as of 05/14/2026.
Donnell William E. reported acquisition or exercise transactions in this Form 4 filing.
Hanover Insurance Group director William E. Donnell received an equity award of 843 shares of common stock. The shares were granted at no cash cost as restricted stock units under the company’s 2022 Long-Term Incentive Plan and will vest on the earlier of one year from the grant date or the next annual shareholder meeting. After this award, Donnell holds 843 shares directly, and a footnote notes an additional 977 shares held indirectly in a Rabbi Trust under deferral agreements.
Ward Elizabeth A reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP director Elizabeth A. Ward received an equity grant of 843 shares of common stock in the form of restricted stock units at no cost. Following this grant, she directly owns 5,879 shares. The units were granted under the 2022 Long-Term Incentive Plan and vest on the earlier of one year from grant or the next annual meeting.
LANE KATHY S reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP, INC. director Kathy S. Lane received an equity grant tied to company performance and retention. She was awarded 843 restricted stock units of common stock under the company’s 2022 Long-Term Incentive Plan at no cash cost. These units vest on the earlier of one year from the grant date or the next annual meeting, and she has elected to defer the shares upon vesting under a deferral agreement. After this award, she directly holds 2,769 common shares, and a footnote states that this does not include 4,829 additional shares held indirectly in a Rabbi Trust under separate deferral arrangements.
RAMRATH JOSEPH R reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP, INC. director Joseph R. Ramrath received a grant of 843 shares of Common Stock in the form of restricted stock units under the company’s 2022 Long-Term Incentive Plan. These units vest on the earlier of one year from grant or the next annual meeting. Following this award, he directly holds 33,830 shares.
Condrin J Paul reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP, INC. director J Paul Condrin reported an equity award rather than a market trade. On 2026-05-12, he received 843 shares of common stock in the form of restricted stock units granted at no cash cost to him.
The award was made under the company’s 2022 Long-Term Incentive Plan and will vest on the earlier of the one-year anniversary of the grant date or the next annual meeting. Following this grant, Condrin directly holds 6,352 shares of Hanover common stock.
Bunting Theodore H JR reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP, INC. director Theodore H. Bunting Jr. received an award of 843 shares of common stock on May 12, 2026, recorded at no cash price per share. These are restricted stock units granted under the company’s 2022 Long-Term Incentive Plan and will vest on the earlier of one year from the grant date or the next annual meeting. Following this grant, Bunting directly owns 7,031 shares of common stock.
Bradicich Kevin reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP director Kevin Bradicich received an equity award. He was granted 843 shares of common stock in the form of restricted stock units at a stated price of $0.00 per share under the company’s 2022 Long-Term Incentive Plan.
The units vest on the earlier of one year from the grant date or the next annual meeting. Following this grant, Bradicich holds 10,092 common shares directly, making this a relatively small, routine compensation-related award rather than a market purchase or sale.
Aristeguieta Francisco reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP director Francisco Aristeguieta received a grant of 843 shares of Common Stock as a compensation award. The grant is in the form of restricted stock units under the 2022 Long-Term Incentive Plan and will vest on the earlier of one year from grant or the next annual meeting, bringing his direct holdings to 5,053 shares.
The Hanover Insurance Group reported several governance and capital actions. The board appointed Patricia A. Norton-Gatto, Senior Vice President and Corporate Controller, as Principal Accounting Officer, replacing CFO Jeffrey M. Farber in that role. Shareholders re-elected eight directors, approved the advisory vote on executive compensation, and ratified PricewaterhouseCoopers LLP as independent auditor for 2026, each with strong support.
The board also terminated the prior share repurchase program and authorized a new $700 million share repurchase program with no time limit, replacing a program that had about $63 million remaining. Repurchases may occur in the open market, through privately negotiated or accelerated transactions, or other methods, at the company’s discretion.